L. Musatti

Most-cited papers

1. Pregnancy outcome after treatment with the ergot derivative, cabergoline.

   E. Robert, L. Musatti, G. Piscitelli, C. Ferrari

   1996Reproductive Toxicology169 citations

   Semantic Scholar

   Save

2. Inhibition of lipolysis by nicotinic acid and by acipimox

   Luciano M. Fuccella, Giancarlo Goldaniga, P. Lovisolo, E. Maggi +3 more

   1980Clinical pharmacology and therapy141 citations

   Semantic Scholar

   Save

3. Treatment of macroprolactinoma with cabergoline: a study of 85 patients

   C. Ferrari, R. Abs, J. Bevan, G. Brabant +7 more

   1997Clinical Endocrinology138 citations

   Semantic Scholar

   Save

4. Bioavailability and Pharmacokinetics in Man of Acipimox, a New Antilipolytic and Hypolipemic Agent

   L. Musatti, E. Maggi, E. Moro, G. Valzelli +1 more

   1981Journal of International Medical Research42 citations

   Semantic Scholar

   Save

5. Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial.

   Gaetano Crepaldi, P. Avogaro, G. Descovich, T. Di Perri +5 more

   1988Atherosclerosis33 citations

   Semantic Scholar

   Save

6. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.

   C. Efthymiopoulos, M. Benedetti, I. Poggesi, F. Ruff +2 more

   1993The´rapie (Paris)11 citations

   Semantic Scholar

   Save

7. Acipimox-induced facial skin flush: Frequency, thermographic evaluation and relationship to plasma acipimox level

   A. Pontiroli, B. Fattor, G. Pozza, E. Pianezzola +2 more

   2005European Journal of Clinical Pharmacology10 citations

   Semantic Scholar

   Save

8. Acipimox stimulates skin blood flow by a cyclo-dxygenase-dependent mechanism

   A. Edlund, L. Musatti, Å. Wennmalm

   2007European Journal of Clinical Pharmacology7 citations

   Semantic Scholar

   Save

9. Plasma free fatty acids and serum insulin in subjects feeding at 12-hour intervals; effects of methionyl growth hormone and of acipimox, an inhibitor of lipolysis

   A. Pontiroli, R. Lanzi, M. Monzani, L. Musatti +2 more

   1992Journal of Endocrinological Investigation4 citations

   Semantic Scholar

   Save

10. Bioavailability of a sustained release formulation of acipimox, following a single dose in healthy volunteers in fasting and fed conditions

    C. Efthymiopoulos, M. Benedetti, F. Ruff, C. Advenier +1 more

    19902 citations

    Semantic Scholar

    Save

11. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration of a sustained release formulation to healthy volunteers

    C. Efthymiopoulos, D. Edwards, M. Strolin‐Benedetti, F. Ruff +3 more

    19931 citations

    Semantic Scholar

    Save

12. Effect of acipimox on plasma lipids in hypertriglyceridaemic subjects. A double blind cross-over trial

    P. Odetti, G. Carta, D. Boeri, M. Maiello +2 more

    19851 citations

    Semantic Scholar

    Save

13. Skin flush is a dose-dependent side effect of acute acipimox administration

    B. Fattor, A. Pontiroli, C. Berra, G. Pozza +2 more

    19900 citations

    Semantic Scholar

    Save